New advances on Au–magnetic organic hybrid core–shells in MRI, CT imaging, and drug delivery

Abstract

Magnetic nanoparticles have been studied for scientific and technological applications such as magnetic storage media, contrast agents for magnetic resonance imaging, biolabelling, separation of biomolecules, and magnetic-targeted drug delivery.

Recent advances in the application of magnetic bio-polymers as catalysts in multicomponent reactions

“…According to the functional groups on the magnetic nanoparticles, the catalysts can be grouped in various categories including, Lewis and Brønsted acids and bases. 40,41 In continuation of our research, 42–44 in this review, the importance of nanomagnetic bio-polymers is studied in multicomponent reactions. Multi-component reactions (MCRs) are essential tools in medicinal and organic chemistry, which have various advantages including simplicity, easy workup, availability, and reduced generation of waste.…”

Recent advances in covalent organic frameworks (COFs) for wound healing and antimicrobial applications

“…74 Since the usage of the solvent DMF alongside other reagents was ascertained as the main source of nitrosamine impurities, this should be considered in future explorations to avoid possible toxicity. 67 In continuation of our ongoing research on medicinal chemistry and drugs, 75,76 herein, we aim to recapitulate the quantitative and qualitative studies on nanoporous materialbased COFs in wound healing studies with antibacterial attributes.…”

Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy

“…Today, the development of nanotechnology has resulted in the creation of several multidisciplinary research domains, namely bionanotechnology, with special contributions in biomedicine and cancer nanomedicine [ 1 , 2 , 3 , 4 , 5 , 6 ]. An assortment of nanoparticles and nanoarchitectures has been designed with satisfactory biocompatibility and targeting properties for a wide range of biomedical and clinical applications; however, due to the stringent regulatory necessities, only a handful of them have entered into clinical trials/studies.…”